Sexual well-being and diurnal cortisol after prostate cancer treatment

Dados Bibliográficos

ID4227002
AutoresMichael A Hoyt (0000-0003-2274-1902, Hunter College, City University of New York, USA), Allison E Gaffey (0000-0002-2960-2772, Rush University Medical Center), Ashley W Wang (Hunter College, City University of New York, USA), Ashley Wang (0000-0001-9740-2345), Mark S Litwin (0000-0002-2318-344X, University of California, Los Angeles), Catalina J Lawsin (Rush University Medical Center)
Ano2020
Volume25
Fascículo10-11
Páginas1796-1801
Data de publicação2020-09-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoJournal of Health Psychology (JOURNAL)
Identificadores do periódicoISSN: 1359-1053 • E-ISSN: 1461-7277
EditoraSAGE Publications Inc (PUBLISHER)
DOI10.1177/1359105318772655
PMID29696999
OpenAlexW2802247243
IdiomaEN
Referências citadas28

Sexual dysfunction and psychological distress are common after prostate cancer. Research has not examined the role of neuroendocrine markers of stress (e.g. cortisol). This study examines whether sexual functioning or sexual bother is associated with diurnal cortisol. Men treated for prostate cancer completed the University of California-Los Angeles Prostate Cancer Index and provided saliva samples four times daily for cortisol assessment. Higher sexual bother, but not sexual functioning, was associated with steeper cortisol slope. Better sexual functioning, and not sexual bother, was significantly associated with the cortisol awakening response. Assessment of stress and stress-reducing interventions might be warranted in sexual rehabilitation after prostate cancer

Cancer · Distress · Prostate · Prostate cancer · Saliva · Sexual dysfunction · Cancer survivorship and care · Cancer, Stress, Anesthesia, and Immune Response · Medicine · Psychology · Stress Responses and Cortisol · Clinical Psychology · Internal Medicine · Oncology